Release of lysosomal enzymes in experimental inflammations: effects of anti-inflammatory drugs.
D000135:Acid Phosphatase / Q000032:analysis; D000469:Alkaline Phosphatase / Q000032:analysis; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D001241:Aspirin / Q000494:pharmacology; D001623:Betamethasone / Q000494:pharmacology; D002351:Carrageenan / Q000494:pharmacology; D003907:Dexamethasone / Q000494:pharmacology; D004487:Edema / Q000139:chemically induced; D005260:Female; D005966:Glucuronidase / Q000032:analysis; D006596:Hexosaminidases / Q000032:analysis; D007213:Indomethacin / Q000494:pharmacology; D007249:Inflammation / Q000139:chemically induced / Q000201:enzymology*; D008247:Lysosomes / Q000201:enzymology*; D008727:Methotrexate / Q000494:pharmacology; D009761:Nystatin / Q000494:pharmacology; D010653:Phenylbutazone / Q000494:pharmacology; D011239:Prednisolone / Q000494:pharmacology; D051381:Rats; D013997:Time Factors
D000893:Anti-Inflammatory Agents; D009761:Nystatin; D003907:Dexamethasone; D002351:Carrageenan; D001623:Betamethasone; D011239:Prednisolone; D000469:Alkaline Phosphatase; D000135:Acid Phosphatase; D006596:Hexosaminidases; D005966:Glucuronidase; D010653:Phenylbutazone; D001241:Aspirin; D007213:Indomethacin; D008727:Methotrexate